# Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia

> **NCT04529382** · — · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 78 (estimated)

## Conditions studied

- Fetal and Neonatal Alloimmune Thrombocytopenia
- Long Term Adverse Effects
- Neurodevelopmental Abnormality
- Intravenous Immunoglobulin Adverse Reaction

## Interventions

- **DIAGNOSTIC_TEST:** Cognitive testing (Bayley III, WPPSI III and WISC V)

## Key facts

- **NCT ID:** NCT04529382
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-17
- **Primary completion:** 2020-12-17
- **Final completion:** 2021-12-17
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2020-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529382, "Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04529382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*